Analytical Data
-
基因名
EIF3H
- Application
-
别名
eIF-3-gamma; eIF3 gamma; eIF3 p40; eIF3 p40 subunit; eIF3h; EIF3H_HUMAN; EIF3S3; Eukaryotic translation initiation factor 3 subunit 3
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P07911
-
表达区间
1-352aa
-
氨基酸序列
MASRKEGTGSTATSSSSTAGAAGKGKGKGGSGDSAVKQVQIDGLVVLKIIKHYQEEGQGTEVVQGVLLGLVVEDRLEITNCFPFPQHTEDDADFDEVQYQMEMMRSLRHVNIDHLHVGWYQSTYYGSFVTRALLDSQFSYQHAIEESVVLIYDPIKTAQGSLSLKAYRLTPKLMEVCKEKDFSPEALKKANITFEYMFEEVPIVIKNSHLINVLMWELEKKSAVADKHELLSLASSNHLGKNLQLLMDRVDEMSQDIVKYNTYMRNTSKQQQQKHQYQQRRQQENMQRQSRGEPPLPEEDLSKLFKPPQPPARMDSLLIAGQINTYCQNIKEFTAQNLGKLFMAQALQEYNN
-
分子量
40.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Identification
Protein Description
PIK3Cd (phosphoinositide 3-kinase, catalytic subunit delta) is a critical member of the class I PI3K family, playing a pivotal role in various cellular processes, including growth, proliferation, and survival. This enzyme is predominantly expressed in immune cells, where it regulates signaling pathways essential for adaptive immunity and inflammation. Research has shown that aberrant PIK3Cd activity is linked to several immune disorders, including autoimmune diseases and cancers, emphasizing its potential as a therapeutic target. The functional characterization of PIK3Cd through recombinant protein studies allows for a deeper understanding of its enzymatic mechanisms and interactions with other signaling molecules. This knowledge is crucial for developing specific inhibitors that can modulate its activity, providing novel treatment strategies for diseases associated with PIK3Cd dysregulation. The exploration of PIK3Cd recombinant proteins not only enhances our understanding of its biological roles but also aids in the identification of biomarkers for disease prognosis and therapeutic response. Thus, continued research on PIK3Cd is vital for unlocking novel interventions in immunology and oncology.
